Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-072154
Filing Date
2025-08-05
Accepted
2025-08-05 17:00:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 27342
  Complete submission text file 0001213900-25-072154.txt   29064
Mailing Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043 6502372700
NeuroPace Inc (Subject) CIK: 0001528287 (see all company filings)

EIN.: 223550230 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92504 | Film No.: 251185944
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830 4752083111
Soleus Capital Master Fund, L.P. (Filed by) CIK: 0001812275 (see all company filings)

EIN.: 981413657 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A